Inventor
BAKTHAVATCHALAM RAJAGOPAL
US40 patents
⚠️ This page may combine multiple inventors who share the name “BAKTHAVATCHALAM RAJAGOPAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROGEN CORP
14 patentsUS6723730B2Apr 20, 2004
Capsaicin receptor ligands
NEUROGEN CORP105 citations96
US7074799B2Jul 11, 2006
Substituted quinazolin-4-ylamine analogues
NEUROGEN CORP48 citations95
US6569861B2May 27, 2003
Melanin concentrating hormone receptor ligands
NEUROGEN CORP33 citations93
US7566712B2Jul 28, 2009
Biaryl piperazinyl-pyridine analogues
NEUROGEN CORP11 citations84
US7488740B2Feb 10, 2009
Substituted quinolin-4-ylamine analogues
NEUROGEN CORP17 citations83
US7304059B2Dec 4, 2007
Substituted quinazolin-4-ylamine analogues
NEUROGEN CORP10 citations83
US8003656B2Aug 23, 2011
2-phenoxy pyrimidinone analogues
NEUROGEN CORP10 citations82
US7432275B2Oct 7, 2008
Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
NEUROGEN CORP18 citations82
US6753336B2Jun 22, 2004
Melanin concentrating hormone receptor ligands
NEUROGEN CORP7 citations74
US7329664B2Feb 12, 2008
Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
NEUROGEN CORP5 citations62
US6906075B2Jun 14, 2005
Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
NEUROGEN CORP3 citations60
US7935702B2May 3, 2011
Substituted biaryl quinolin-4-ylamine analogues
NEUROGEN CORP6 citations59
US7323478B2Jan 29, 2008
Melanin concentrating hormone receptor ligands
NEUROGEN CORP0 citations52
US7241765B2Jul 10, 2007
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
NEUROGEN CORP0 citations50
DU PONT PHARM CO
8 patentsUS6107301AAug 22, 2000
1N-alkyl-N-arylpyrimidinamines and derivatives thereof
DU PONT PHARM CO192 citations97
US6143743ANov 7, 2000
Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
DU PONT PHARM CO41 citations94
US6271380B1Aug 7, 2001
1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
DU PONT PHARM CO18 citations92
US6258809B1Jul 10, 2001
6-aryloxy and arylthiopurines
DU PONT PHARM CO21 citations92
US6245769B1Jun 12, 2001
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders
DU PONT PHARM CO25 citations92
US6124300ASep 26, 2000
Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives
DU PONT PHARM CO32 citations92
US6107300AAug 22, 2000
Arylamino fused pyrimidines
DU PONT PHARM CO35 citations92
US5912348AJun 15, 1999
Method of making arylamino triazolopyridines
DU PONT PHARM CO0 citations40
BRISTOL MYERS SQUIBB PHARMA CO
8 patentsUS6448261B1Sep 10, 2002
Arylamino fused pyridines
BRISTOL MYERS SQUIBB PHARMA CO55 citations95
US6589952B2Jul 8, 2003
Imidazo[1,2-a]pyrazines for the treatment of neurological disorders
BRISTOL MYERS SQUIBB PHARMA CO30 citations92
US6642230B2Nov 4, 2003
Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
BRISTOL MYERS SQUIBB PHARMA CO22 citations91
US6630476B2Oct 7, 2003
Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
BRISTOL MYERS SQUIBB PHARMA CO13 citations84
US6362180B1Mar 26, 2002
Imidazopyridines for the treatment of neurological disorders
BRISTOL MYERS SQUIBB PHARMA CO14 citations82
US6734185B2May 11, 2004
Pyrrolo[3,4-d]pyrimidines as corticotropin releasing factor (CRF) antagonists
BRISTOL MYERS SQUIBB PHARMA CO10 citations74
US6593337B1Jul 15, 2003
Tricyclic compounds useful as HIV reverse transcriptase inhibitors
BRISTOL MYERS SQUIBB PHARMA CO3 citations62
US7045529B2May 16, 2006
Imidazopyrimidinyl and imidazopyri dinyl derivatives
BRISTOL MYERS SQUIBB PHARMA CO4 citations60
JANSSEN PHARMACEUTICA NV
3 patentsUS9453002B2Sep 27, 2016
Substituted imidazoles as N-type calcium channel blockers
JANSSEN PHARMACEUTICA NV18 citations90
US10653673B2May 19, 2020
Substituted imidazoles as N-type calcium channel blockers
JANSSEN PHARMACEUTICA NV0 citations50
US9974775B2May 22, 2018
Substituted imidazoles as N-type calcium channel blockers
JANSSEN PHARMACEUTICA NV1 citations50
BRISTOL MYERS SQUIBB CO
2 patentsUS6525056B2Feb 25, 2003
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders
BRISTOL MYERS SQUIBB CO22 citations92
US6518271B1Feb 11, 2003
1H-imidazo[4,5-d]pyridazin-7-one, and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
BRISTOL MYERS SQUIBB CO11 citations73